Chisato Ogawa

Title: Chisato Ogawa: Innovator in Pyrimidine Derivatives

Introduction

Chisato Ogawa is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on pyrimidine derivatives. Her research focuses on developing compounds that can effectively treat various diseases, including irritable bowel syndrome (IBS).

Latest Patents

Chisato Ogawa holds a patent for pyrimidine derivatives, which are represented by a specific formula or a salt thereof. This invention is notable for its ability to exhibit both 5-HT agonistic and antagonistic activities simultaneously. Such properties make these derivatives particularly useful in the therapy and treatment of diseases like IBS. The therapeutic method she developed involves administering either a 5-HT antagonistic agent that concurrently exhibits 5-HT agonistic activity or administering both agents simultaneously, in sequence, or at intervals.

Career Highlights

Chisato Ogawa has dedicated her career to advancing pharmaceutical research. She is currently associated with Aska Pharmaceutical Co., Ltd., where she continues to explore innovative solutions for complex medical conditions. Her work has garnered attention for its potential to improve patient outcomes through novel therapeutic approaches.

Collaborations

Chisato has collaborated with notable colleagues, including Michitaka Sato and Teruaki Matsui. These partnerships have enriched her research and contributed to the development of her patented inventions.

Conclusion

Chisato Ogawa's contributions to the field of medicinal chemistry, particularly through her work on pyrimidine derivatives, highlight her role as an influential inventor. Her innovative approaches to treating diseases like IBS demonstrate the impact of her research on healthcare.